Newsletter
Best Papers in General Surgery
The five that matter, every day.
A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.
Motion data from robotic gallbladder dissection identified surgeon experience about as well as motion data combined with clinical details.
Five years after surgery for low rectal cancer, patients operated on robotically did as well as those operated on laparoscopically, according to a randomized trial from three Korean centres.
Closing a midline laparotomy with small, closely spaced fascial bites prevents more incisional hernias than the traditional large-bite technique, and the benefit lasts beyond two years.
Checking blood flow with a green fluorescent dye was linked to fewer leaks where the two ends of the oesophagus are joined.
Patients with better blood nutrition scores lived longer after surgery for gallbladder cancer, in a study of 1,312 patients.
Drugs given around liver cancer surgery have mostly failed, but one recent trial showed a real benefit.
Over five decades, surgery went from the most disruptive research field to the only one where papers, on average, reinforce existing ideas rather than redirect the field.
After major emergency abdominal surgery, patients who develop lung complications face much higher death risk, most sharply in the first days.
Members of the Society of American Gastrointestinal and Endoscopic Surgeons want a say in how surgery will work beyond Earth, and robotics tops their list.
